Dr. Scott Richard Silva, MD, PhD

Dr. Silva practices at UofL Health - UofL Hospital in Louisville, Kentucky, part of UofL Health.

Dr. Silva's NPI, 1487097390, was assigned on April 10, 2013. Dr. Silva graduated from University of Kentucky College of Medicine in 2013. Dr. Silva holds Kentucky license 51492.

Dr. Silva's primary practice is UofL Health - UofL Hospital, at 530 South Jackson Street, Louisville, KY 40202 in Jefferson County. The practice phone is (502) 562-3000.

Dr. Silva's primary practice is UofL Health - UofL Hospital in Louisville, Kentucky, part of UofL Health. Dr. Silva is also affiliated with UofL Health - Jewish Hospital. The medical group on file is UofL Physicians, Radiology. Dmand AI also links Dr. Silva to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silva practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Silva's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Silva's licenses on file in 2 states: Kentucky and Illinois.

CMS data shows 1,152 Medicare services from Dr. Silva across 16 procedure codes in 2024, for 193 Medicare patients. Medicare paid $78,807 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 193 Medicare patients who saw Dr. Silva in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have cancer, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Silva's median patient age at 72, with 33% women.

In 2024, Dr. Silva wrote 192 Medicare Part D claims for 62 patients. 98% of them were for generic drugs. CMS names the drug for 148 of them, across 4 drugs with 11 or more claims each, at $1,582 in total drug cost. In 2023, CMS named 66 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Silva for performance year 2024, reported as part of a group. Dr. Silva accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Silva as offering telehealth.

Dmand AI links 17 papers to Dr. Silva, published from 2016 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Brachytherapy, Endometrial Neoplasms and Radiotherapy Dosage. Dr. Silva has published most often in Brachytherapy. Dr. Silva's most frequent co-authors are Harriet Belding Eldredge-Hindy, MD, Daniel Stewart Metzinger, MD and Leonid Borisovich Reshko, MD.

Dmand AI links Dr. Silva to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 74 general payments to Dr. Silva from 27 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $181.

Dr. Silva graduated from University of Kentucky College of Medicine in 2013.